The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions
A combination of the use of PDI targets and prediction of human pharmacokinetics allowed effective doses of NOSO-502 in man to be estimated.
Institutions
- University of Liverpool (GB)
- National and Kapodistrian University of Athens (GR)
- Southmead Hospital (GB)
- Erasmus MC (NL)
- GGD Haaglanden (NL)
- Cyclopharma (France) (FR)
- Medical University of Vienna (AT)
- Evotec (United States) (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1093/jac/dkag106
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00